Riccardo Papa

The complicated path of COVID-19 eradication

Since the appearance of the SARS-CoV-2 last winter, scientists immediately understood the danger of its spread, but they were anticipating it was not going to mutate as quickly as the viruses that cause the AIDS or flu, for example. As more data became available for scientists to refine their knowledge, they realized that the SARS-CoV-2 is mutating more rapidly than hoped or expected. This is why you regularly read about novel strains of the COVID-19 usually labeled with the name of the country where it was first identified. However, while these new variants are referred to as Brazilian, South African or British, it does not ensure that they originated in those countries. It only means that they were first noted within their borders. It is important also to clarify that these novel coronavirus strains refer to the same SARS-CoV-2 virus that has been circulating since the beginning of the pandemic. Thus, the virus is the same since the origin but with some changes that we call mutations.

Otras columnas de Riccardo Papa

domingo, 31 de enero de 2021

El complicado camino hacia la erradicación del COVID-19

Aunque necesitamos entender si las variantes actuales ‘revigorizan’ ciertas características del virus, y cómo lo hacen, posiblemente el enfoque principal debería estar en lo que podría venir por delante, ya que es probable que ocurran nuevos cambios, dice Riccardo Papa

viernes, 25 de diciembre de 2020

Mutations are part of life: the biology of COVID-19

The current pandemic highlights not only the need to provide fast scientific studies and recommendations, but also problems that are more connected to our society and how opinions and behaviors are guided and respected by the general public, writes Riccardo Papa

💬See comments
Popular en la Comunidad


Nuestro sitio no es visible desde este navegador.

Te invitamos a descargar cualquiera de estos navegadores para ver nuestras noticias: